BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
10 hedge funds and large institutions have $6.67M invested in BioAmber Inc. in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
9% less funds holding
Funds holding: 11 → 10 (-1)
20% less capital invested
Capital invested by funds: $8.36M → $6.67M (-$1.68M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$52.1K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$17.3K |
| 3 |
Barclays
London,
United Kingdom
|
+$338 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WRF
1
Waddell & Reed Financial
Overland Park,
Kansas
| $4.09M | – | – | – |
|
|
PRCM
2
Pine River Capital Management
Minnetonka,
Minnesota
| $706K | – | – | – |
|
|
ACPU
3
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $530K | – | – | – |
|
|
LCS
4
Levin Capital Strategies
New York
| $468K | +$52.1K | +30,066 | +10% |
|
|
MCM
5
Moore Capital Management
New York
| $360K | – | – | – |
|
|
SFM
6
Soros Fund Management
New York
| $274K | – | – | – |
|
|
MIM
7
Monashee Investment Management
Boston,
Massachusetts
| $212K | – | – | – |
|
|
PWAM
8
Park West Asset Management
San Francisco,
California
| $21K | – | – | – |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $14K | +$17.3K | +10,000 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$2K | -1,000 | Closed |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$1K | -556 | Closed |
|
|
12
Barclays
London,
United Kingdom
| – | +$338 | +195 | +315% |
|
BIOA.WS Hedge Fund Activity: Q4 2015 in Review
10 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q4 2015, worth a combined $6.67M — down 20% from $8.36M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIOA.WS and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Levin Capital Strategies, adding an estimated $52.1K. The largest seller was UBS Group, exiting entirely with an estimated $2K sold.
- 10 institutional investors held BioAmber Inc. (BIOA.WS) as of Q4 2015, down from 11 in Q3 2015.
- Funds reported $6.67M of BioAmber Inc. stock for Q4 2015, down 20% quarter-over-quarter.
- 1 fund opened new BioAmber Inc. positions in Q4 2015 and 2 closed out, a net change of -1 holder.
- The largest BioAmber Inc. buyer in Q4 2015 was Levin Capital Strategies, an estimated $52.1K added.
- The largest BioAmber Inc. seller in Q4 2015 was UBS Group, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2015.